References
- Shriner DL, McCoy DK, Goldberg DJ, et al. Mohs micrographic surgery. J Am Acad Dermatol. 1998;39:79–97.
- Snow SN, Madjar DD, Jr. Mohs surgery in the management of cutaneous malignancies. Clin Dermatol. 2001;19:339–347.
- Mosterd K, Krekels GA, Nieman FH, et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol. 2008;9:1149–1156.
- Lear W, Mittmann N, Barnes E, et al. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study. J Cutan Med Surg. 2008;12:82–87.
- Kauvar AN, Cronin T, Jr., Roenigk R, et al. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods. Dermatol Surg. 2015;41:550–571.
- van Loo E, Mosterd K, Krekels GA, et al. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. Eur J Cancer. 2014;50:3011–3020.
- Cernea SS. Experiência do grupo de cirurgia micrográfica de Mohs do HCFMUSP: dezembro/1989 a abril/1993. An Bras Dermatol. 1994;69:365–373.
- Bichakjian CK, Olencki T, Aasi SZ, et al. Basal cell skin cancer, version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14:574–597.
- Connolly SM, Baker DR, Coldiron BM, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. Dermatol Surg. 2012;38:1582–1603.
- Flohil SC, van Dorst AM, Nijsten T, et al. Mohs micrographic surgery for basal cell carcinomas: appropriateness of 'Rotterdam' criteria and predictive factors for three or more stages. J Eur Acad Dermatol Venereol. 2013;27:1228–1235.
- Leibovitch I, Huilgol SC, Selva D, et al. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005;53:445–451.
- Cernea SS, Gontijo G, Pimentel ER, et al. Indication guidelines for Mohs micrographic surgery in skin tumors. An Bras Dermatol. 2016;91:621–627.
- Batra RS, Kelley LC. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol. 2002;138:1043–1051.
- Hoorens I, Batteauw A, Van Maele G, et al. Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread. Br J Dermatol. 2016;174:847–852.
- Coldiron B, Storrs P. Why appropriate use criteria for Mohs micrographic surgery? J Am Acad Dermatol. 2012;67:551.
- Kaplan AL, Weitzul SB, Taylor RS. Longitudinal diminution of tumor size for basal cell carcinoma suggests shifting referral patterns for Mohs surgery. Dermatol Surg. 2008;34:15–19.
- Beach RA, Zhang T, Goldberg LH, et al. Tumor characteristics of Mohs surgery patients in Ottawa, Canada versus Houston, Texas–a consequence of access to care? Dermatol Surg. 2011;37:1106–1112.
- Chong T, Tristani-Firouzi P, Bowen GM, et al. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center. Dermatol Surg. 2015;41:889–895.
- Ruiz ES, Karia PS, Morgan FC, et al. Multiple Mohs micrographic surgery is the most common reason for divergence from the appropriate use criteria: a single institution retrospective cohort study. J Am Acad Dermatol. 2016;75:830–831.
- Codazzi D, Van Der Velden J, Carminati M, et al. Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management. J Plast Surg Hand Surg. 2014;48:38–43.
- Orengo IF, Salasche SJ, Fewkes J, et al. Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane. J Am Acad Dermatol. 1997;37:395–397.
- Alonso T, Sanchez P, Gonzalez A, et al. Mohs micrographic surgery: our first 100 patients. Actas Dermosifiliogr. 2008;99:275–280.
- Smeets NW, Krekels GA, Ostertag JU, et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet. 2004;364:1766–1772.
- Gurgen J, Gatti M. Epiluminescence microscopy (dermoscopy) versus visual inspection during Mohs microscopic surgery of infiltrative basal cell carcinoma. Dermatol Surg. 2012;38:1066–1069.
- Suzuki HS, Serafini SZ, Sato MS. Utility of dermoscopy for demarcation of surgical margins in Mohs micrographic surgery. An Bras Dermatol. 2014;89:38–43.
- Alam M, Berg D, Bhatia A, et al. Association between number of stages in Mohs micrographic surgery and surgeon-, patient-, and tumor-specific features: a cross-sectional study of practice patterns of 20 early- and mid-career Mohs surgeons. Dermatol Surg. 2010;36:1915–1920.
- Roozeboom MH, Mosterd K, Winnepenninckx VJ, et al. Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013;27:894–898.
- Mosterd K, Thissen MR, van Marion AM, et al. Correlation between histologic findings on punch biopsy specimens and subsequent excision specimens in recurrent basal cell carcinoma. J Am Acad Dermatol. 2011;64:323–327.
- Smith SP, Grande DJ. Basal cell carcinoma recurring after radiotherapy: a unique, difficult treatment subclass of recurrent basal cell carcinoma. J Dermatol Surg Oncol. 1991;17:26–30.